109 related articles for article (PubMed ID: 9824969)
1. [Recombinant interferons: pharmacokinetics and therapeutic implications].
Läer S
Dtsch Med Wochenschr; 1998 Oct; 123(44):1320-7. PubMed ID: 9824969
[No Abstract] [Full Text] [Related]
2. [Natural and recombinant interferons].
Läer S
Med Monatsschr Pharm; 1999 Nov; 22(11):340-5. PubMed ID: 10596267
[No Abstract] [Full Text] [Related]
3. Interferons: their role in clinical practice.
Ucar R; Sanwo M; Ucar K; Beall G
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):377-86; quiz 386-9. PubMed ID: 7583859
[TBL] [Abstract][Full Text] [Related]
4. [Interferons. Structure, functions and therapeutic applications of interferons].
Marcellin P
Ann Med Interne (Paris); 1993; 144(8):539-47. PubMed ID: 7513979
[No Abstract] [Full Text] [Related]
5. [Interferon: validity, risks, prospects of clinical use].
Rossi GB; Belardelli F
Epidemiol Prev; 1987 Mar; 9(30):13-5. PubMed ID: 2466676
[No Abstract] [Full Text] [Related]
6. Interferons: biochemistry and mechanisms of action.
Tyring SK
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 2):1350-3. PubMed ID: 7537022
[No Abstract] [Full Text] [Related]
7. [Antiviral activity of interferons in animal experiments].
Pshenichnov VA; Malinkin IuN
Vopr Virusol; 1988; 33(3):261-7. PubMed ID: 2459847
[No Abstract] [Full Text] [Related]
8. [Mechanisms of activity and therapeutic applications of interferons].
Roos W
Pharmazie; 1989 Jun; 44(6):361-4. PubMed ID: 2475876
[No Abstract] [Full Text] [Related]
9. Interferons in dermatology: biology, pharmacology, and clinical applications.
Ruszczak Z; Schwartz RA
Adv Dermatol; 1997; 13():235-88. PubMed ID: 9551146
[No Abstract] [Full Text] [Related]
10. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
11. Interferon.
Trofatter KF
Obstet Gynecol Clin North Am; 1987 Jun; 14(2):569-79. PubMed ID: 2448715
[TBL] [Abstract][Full Text] [Related]
12. Interferon in multiple sclerosis.
Hendel DL; Hart LL
DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
[No Abstract] [Full Text] [Related]
13. [Anti-fibrotic effects of interferons. Mechanisms of action and therapeutic prospects].
Pilette C; Fort J; Rifflet H; Calès P
Gastroenterol Clin Biol; 1997; 21(6-7):466-71. PubMed ID: 9295973
[No Abstract] [Full Text] [Related]
14. [Interferons: structure, functions and therapeutic applications].
Marcellin P
J Chir (Paris); 1994; 131(8-9):381-90. PubMed ID: 7531204
[No Abstract] [Full Text] [Related]
15. [Biosimilar products--cheaper version of biological drugs. New possibilities within several therapeutic fields].
Mellstedt H
Lakartidningen; 2009 Jun 3-9; 106(23):1563-6. PubMed ID: 19583014
[No Abstract] [Full Text] [Related]
16. [Interferons in medicine].
Lucivero G
Recenti Prog Med; 1990 May; 81(5):329-36. PubMed ID: 1696020
[TBL] [Abstract][Full Text] [Related]
17. Interferon in the treatment of cutaneous T-cell lymphoma.
Olsen EA; Bunn PA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1089-107. PubMed ID: 8522486
[TBL] [Abstract][Full Text] [Related]
18. [Metabolism and pharmacokinetics of natural immunomodulators].
Bocci V; Pacini A; Pessina GP; Maioli E
Ann Ist Super Sanita; 1987; 23(4):761-3. PubMed ID: 2454597
[No Abstract] [Full Text] [Related]
19. [Interferon - effects and therapeutic possibilities].
Strander H
Nord Med; 1981 Mar; 96(3):82-3. PubMed ID: 6164976
[No Abstract] [Full Text] [Related]
20. [Interferon: therapeutic uses in reach?].
Lindenmann J
Dtsch Med Wochenschr; 1978 Aug; 103(34):1317-8. PubMed ID: 679829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
